衰弱与血管内胸腹主动脉瘤修复结局的关联
本研究利用2016-2021年全国再入院数据库,纳入择期血管内腹主动脉修复和胸主动脉血管内修复的成人患者,采用医院衰弱风险评分等三种工具评估衰弱与不良结局的关联。结果显示医院衰弱风险评分识别的衰弱与死亡和围术期并发症风险升高相关,且该评分预测效能最优。
要点
- 医院衰弱风险评分可识别血管内主动脉修复术后高危患者。
- 衰弱与死亡、呼吸、肾脏及血栓栓塞并发症风险增加相关。
- 医院衰弱风险评分预测效能优于其他两种衰弱工具。
核心结论
- 医院衰弱风险评分是预测血管手术脆弱人群不良结局的可靠工具。
研究设计与样本
- 基于2016-2021年全国再入院数据库的回顾性队列研究,纳入择期血管内腹主动脉修复和胸主动脉血管内修复的成人患者。
主要发现
- 血管内腹主动脉修复患者中10.1%被医院衰弱风险评分归类为衰弱,胸主动脉血管内修复患者中该比例为23.4%。
- 多变量调整后,医院衰弱风险评分识别的衰弱与死亡和围术期并发症(包括呼吸、肾脏及血栓栓塞事件)风险升高相关。
- 医院衰弱风险评分在预测结局方面的区分度、敏感性和特异性均优于行政风险分析指数和约翰霍普金斯调整临床分组模型。
临床怎么用
- 可考虑使用医院衰弱风险评分对接受血管内主动脉修复的患者进行术前衰弱筛查,以优化患者选择和术后护理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Given the increasing use of endovascular repair of aortic aneurysms in elderly patients, accurate identification of patients with frailty is crucial for optimizing patient selection and care. The present study represents the first application of the recently developed Hospital Frailty Risk Score and its comparison with commonly used surgical frailty indices to investigate the association between frailty and outcomes after endovascular abdominal repair and thoracic endovascular aortic repair using a nationally representative database. METHODS: Adults undergoing elective endovascular abdominal repair and thoracic endovascular aortic repair for unruptured aortic aneurysms were identified in the 2016-2021 Nationwide Readmission Database and grouped into non-Frail and Frail cohorts using the Hospital Frailty Risk Score, Administrative Risk Analysis Index, and Johns Hopkins Adjusted Clinical Groups instruments. Multivariable regression models and area under the receiver operating characteristic curve were used to assess and compare the associations between frailty, adverse outcomes, and resource use. RESULTS: Of an estimated 105,265 patients who underwent endovascular abdominal repair and 16,595 patients who underwent thoracic endovascular aortic repair, 10.1% and 23.4% were classified as frail by Hospital Frailty Risk Score, respectively. After multivariable adjustment, frailty identified by Hospital Frailty Risk Score was associated with increased odds of mortality and perioperative complications, including respiratory, renal, and thromboembolic events. The Hospital Frailty Risk Score demonstrated the greatest discriminatory power, sensitivity, and specificity in predicting outcomes, outperforming the models that included Administrative Risk Analysis Index and Johns Hopkins Adjusted Clinical Groups. CONCLUSION: The Hospital Frailty Risk Score appears to be a reliable frailty instrument for predicting adverse outcomes in vulnerable populations undergoing vascular procedures. Given the critical role of accurately identifying frailty to optimize postoperative care and resource allocation, selecting the most appropriate frailty instrument is essential.
引用
- Yalzadeh D, Kwon OJ, Tabibian D, et al. Association of frailty with outcomes of endovascular thoracic and abdominal aneurysm repairs. Surgery. 2025. PMID: 40466559. doi:10.1016/j.surg.2025.109449
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。